✦ LIBER ✦

A Phase I/II Study of Concurrent Abraxane, Carboplatin and IMRT for Locally Advanced Squamous Cell Cancer of the Head and Neck (LASCCHN)

✍ Scribed by Tishler, R.B.; Lorch, J.; Sher, D.; Clark, J.; Chan, A.; Suda, M.; Balboni, T.; Busse, P.; Haddad, R.; Wirth, L.

Book ID: 122466405
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 41 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.796

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of docetaxel and carbop

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

✍ Imjai Chitapanarux; Vicharn Lorvidhaya; Ekasit Tharavichitkul; Somvilai Mayurasa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 138 KB

8562 Phase II study of docetaxel and car

8562 Phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

✍ Chitapanarux, I.; Lorvidhaya, V.; Kamnerdsupaphon, P.; Tharavichitkul, E.; Sitti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Multi-agent concurrent chemoradiotherapy

Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly

✍ Stephanie A. Michal; David J. Adelstein; Lisa A. Rybicki; Cristina P. Rodriguez; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

A phase II study of mitoxantrone in adva

A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck

✍ H. Wheeler; R. L. Woods; J. Page; J. Levi 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 186 KB

Twenty patients with advanced squamous cell carcinomas (SCC) of the head and neck were entered into a phase II study of mitoxantrone at a dosage of either 12 mg/m2 or 14 mg/m2 given at 3 weekly intervals. None of the patients had received prior chemotherapy. One patient had a partial remission. Two

Phase II Study of Concurrent Chemoradiat

Phase II Study of Concurrent Chemoradiation with Bevacizumab and Docetaxel for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

✍ N. Galanopoulos; M. Yao; P. Lavertu; A. Argiris; J. Greskovich; P. Fu; J. Wasman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

649 Update on the toxicity and response

649 Update on the toxicity and response of a phase I trial of concurrent, daily gefitinib and radiation or chemo-radiation for patients with locally advanced squamous cell cancer of the head and neck (LASCCHN)

✍ D. Raben; M. Kane; C. Chen; J. Song; L. Brualdi; A. Raben; K. Hu; S. Gollamudi; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 146 KB